Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PRL action on E2 ovarian secretion.

F Polatti, C Nava, A Brambilla

    Clinical and Experimental Obstetrics & Gynecology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Atomic-scale insights into metal-oxide/graphene heterostructures.

    Journal of physics. Condensed matter : an Institute of Physics journal·2025
    Same author

    Experimental Lung Transplantation Related With HIF-1, VEGF, ROS. Assessment of HIF-1alpha, VEGF, and Reactive Oxygen Species After Competitive Blockade of Chetomin for Lung Transplantation in Rats.

    Physiological research·2024
    Same author

    Maxillofacial Injuries in Padel Game.

    Journal of maxillofacial and oral surgery·2023
    Same author

    Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre.

    International journal of cardiology·2022
    Same author

    Reversible metamorphosis from Fe<sub>3</sub>O<sub>4</sub> to FeO of epitaxial iron oxide films grown on the Fe-p(1 × 1)O surface.

    RSC advances·2022
    Same author

    Hospital workers mental health during the COVID-19 pandemic: methods of data collection and characteristics of study sample in a university hospital in Milan (Italy).

    BMC medical research methodology·2021
    Same journal

    Can ACGME Milestones predict surgical specialty board passage: an example in Obstetrics and Gynecology.

    Clinical and experimental obstetrics & gynecology·2021
    Same journal

    Which patients on a gynecologic oncology service will require perioperative transfusion? A single-center retrospective cohort study.

    Clinical and experimental obstetrics & gynecology·2021
    Same journal

    Cantharidin is Superior to Trichloroacetic Acid for the Treatment of Non-mucosal Genital Warts: A Pilot Randomized Controlled Trial.

    Clinical and experimental obstetrics & gynecology·2018
    Same journal

    A case of placental mesenchymal dysplasia with one year follow-up.

    Clinical and experimental obstetrics & gynecology·2018
    Same journal

    Repeated cesarean scar pregnancy - Case report.

    Clinical and experimental obstetrics & gynecology·2018
    Same journal

    Iatrogenic parasitic myoma on the peritoneum of the right pelvic wall.

    Clinical and experimental obstetrics & gynecology·2018
    See all related articles

    This study found that bromocryptine treatment effectively lowers prolactin (PRL) levels in women with hyperprolactinemic amenorrhea. Ovarian response, measured by estradiol (E2), correlated negatively with prolactin levels.

    Area of Science:

    • Reproductive Endocrinology
    • Pharmacology

    Background:

    • Hyperprolactinemic amenorrhea is a condition affecting women's reproductive health.
    • Bromocryptine is a medication used to treat hyperprolactinemia.

    Purpose of the Study:

    • To investigate the effect of intermittent bromocryptine treatment on hormonal levels in women with hyperprolactinemic amenorrhea.
    • To assess the relationship between prolactin levels and ovarian response (estradiol) during treatment cycles.

    Main Methods:

    • Five women with hyperprolactinemic amenorrhea received intermittent bromocryptine treatment over three cycles (5, 4, and 3 days of treatment followed by 10 days of suspension).
    • Follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), and estradiol (E2) levels were monitored during treatment and suspension phases.

    Related Experiment Videos

    Main Results:

    • Bromocryptine treatment significantly reduced prolactin (PRL) levels.
    • PRL levels returned to baseline during the suspension phases.
    • No significant variations in FSH and LH levels were observed.
    • Estradiol (E2) levels varied with prolactin levels, showing a statistically significant negative correlation between PRL and 17-beta-estradiol.

    Conclusions:

    • Intermittent bromocryptine therapy effectively manages hyperprolactinemia.
    • Prolactin levels directly influence ovarian response (estradiol production) in these patients.